UDD Logo
CRIS - Current Research Information System
New user? Click here to register.Have you forgotten your password?
Communities & Collections
Research Outputs
Fundings & Projects
Researchers
Datasets
Statistics
  1. Home
  2. CRIS
  3. Publications
  4. Complement Component C3 Participates in Early Stages of Niemann–Pick C Mouse Liver Damage
Details

Complement Component C3 Participates in Early Stages of Niemann–Pick C Mouse Liver Damage

Journal
International Journal of Molecular Sciences
ISSN
1422-0067
Date Issued
2020
Author(s)
Andrés D. Klein
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
Javier González de la Vega
Silvana Zanlungo
Type
Resource Types::text::journal::journal article
Scopus ID
2-s2.0-85083042601
WoS ID
WOS:000529890200223
DOI
10.3390/ijms21062127
URL
https://investigadores.udd.cl/handle/123456789/5016
URL Institutional Repository
http://hdl.handle.net/11447/3276
Abstract
<jats:p>Niemann–Pick type C (NPC), a lysosomal storage disorder, is mainly caused by mutations in the NPC1 gene. Niemann–Pick type C patients and mice show intracellular cholesterol accumulation leading to hepatic failure with increased inflammatory response. The complement cascade, which belongs to the innate immunity response, recognizes danger signals from injured tissues. We aimed to determine whether there is activation of the complement system in the liver of the NPC mouse and to assess the relationship between C3 activation, a final component of the pathway, and NPC liver pathology. Niemann–Pick type C mice showed high levels of C3 staining in the liver which unexpectedly decreased with aging. Using an inducible NPC1 hepatocyte rescue mouse model, we restored NPC1 expression for a short time in young mice. We found C3 positive cells only in non-rescued cells, suggesting that C3 activation in NPC cells is reversible. Then, we studied the effect of C3 ablation on NPC liver damage at two postnatal time points, P56 and P72. Deletion of C3 reduced the presence of hepatic CD68-positive cells at postnatal day 56 and prevented the increase of transaminase levels in the blood of NPC mice. These positive effects were abrogated at P72, indicating that the complement cascade participates only during the early stages of liver damage in NPC mice, and that its inhibition may serve as a new potential therapeutic strategy for the disease.</jats:p>
Cite this document
Klein, A. D., González De La Vega, J., & Zanlungo, S. (2020). Complement component c3 participates in early stages of niemann–pick c mouse liver damage. International Journal of Molecular Sciences, 21(6), 2127. https://doi.org/10.3390/ijms21062127
Project(s)
Uncovering modifier genes of lysosomal biology by exploiting the natural genetic variation of inbred mouse strains  
Discovery of a Novel TFEB Regulation Pathway by the c-Abl Kinase Reveals a Common Therapeutic Approach for Sphingolipidosis  
Subjects
cholesterol

; 

complement cascade

; 

foam cells

; 

liver damage

; 

lysosomal storage diseases

; 

niemann–pick type c disease

; 

alanine aminotransferase

; 

aminotransferase

; 

aspartate aminotransferase

; 

cd68 antigen

; 

cholesterol

; 

complement component c3

; 

doxycycline

; 

filipin

; 

tetracycline

; 

animal cell

; 

animal experiment

; 

animal model

; 

animal tissue

; 

article

; 

cell structure

; 

complement activation

; 

controlled study

; 

foam cell

; 

immunohistochemistry

; 

liver cell

; 

liver histology

; 

liver injury

; 

mouse

; 

niemann pick disease

; 

nonhuman

; 

protein expression

; 

staining

; 

tissue section
Logo Universidad de Desarrollo
Encuéntranos en:

Sede Santiago

Av. Plaza 680, Las Condes

Contacto|Mapa

Sede Concepción

Ainavillo 456, Concepción

Contacto|Mapa

Hosting & SupportLogo Scimago Lab

Built with DSpace-CRIS software - Extension maintained and optimized by 4science

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify